메뉴 건너뛰기




Volumn 26, Issue 8, 2009, Pages 665-675

Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: Post Hoc subanalysis of data from two clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

EID: 69049102125     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11316450-000000000-00000     Document Type: Article
Times cited : (3)

References (41)
  • 1
    • 34248364046 scopus 로고    scopus 로고
    • Causes and consequences of chronic kidney disease: Implications for managed health care
    • Weiner DE. Causes and consequences of chronic kidney disease: implications for managed health care. J Manag Care Pharm 2007; 13 (3 Suppl.): S1-9
    • (2007) J Manag Care Pharm , vol.13 , Issue.3 SUPPL.
    • Weiner, D.E.1
  • 2
    • 33750895555 scopus 로고    scopus 로고
    • Pathogenesis of renal anemia
    • Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol 2006; 26 (4): 261-268
    • (2006) Semin Nephrol , vol.26 , Issue.4 , pp. 261-268
    • Nangaku, M.1    Eckardt, K.U.2
  • 3
    • 0034108227 scopus 로고    scopus 로고
    • Pathophysiology of renal anemia
    • Eckardt KU. Pathophysiology of renal anemia. Clin Nephrol 2000; 53 (1 Suppl.): S2-8
    • (2000) Clin Nephrol , vol.53 , Issue.1 SUPPL.
    • Eckardt, K.U.1
  • 4
    • 0035014350 scopus 로고    scopus 로고
    • Prevalence of cardiovascular damage in early renal disease
    • Levin A. Prevalence of cardiovascular damage in early renal disease. Nephrol Dial Transplant 2001; 16 Suppl. 2: 7-11
    • (2001) Nephrol Dial Transplant , vol.16 , Issue.SUPPL. 2 , pp. 7-11
    • Levin, A.1
  • 5
    • 0037166636 scopus 로고    scopus 로고
    • Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994)
    • Astor BC, Muntner P, Levin A, et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002; 162 (12): 1401-1408
    • (2002) Arch Intern Med , vol.162 , Issue.12 , pp. 1401-1408
    • Astor, B.C.1    Muntner, P.2    Levin, A.3
  • 7
    • 1642439065 scopus 로고    scopus 로고
    • Estimating the prevalence of renal insufficiency in seniors requiring long-term care
    • DOI 10.1111/j.1523-1755.2004.00412.x
    • Garg AX, Papaioannou A, Ferko N, et al. Estimating the prevalence of renal insufficiency in seniors requiring longterm care. Kidney Int 2004; 65 (2): 649-653 (Pubitemid 38130661)
    • (2004) Kidney International , vol.65 , Issue.2 , pp. 649-653
    • Garg, A.X.1    Papaioannou, A.2    Ferko, N.3    Campbell, G.4    Clarke, J.-A.5    Ray, J.G.6
  • 10
    • 31544469211 scopus 로고    scopus 로고
    • Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes
    • DOI 10.1093/ndt/gfi209
    • Levin A, Djurdjev O, Duncan J, et al. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006; 21 (2): 370-377 (Pubitemid 43159990)
    • (2006) Nephrology Dialysis Transplantation , vol.21 , Issue.2 , pp. 370-377
    • Levin, A.1    Djurdjev, O.2    Duncan, J.3    Rosenbaum, D.4    Werb, R.5
  • 15
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • DOI 10.1056/NEJMoa041031
    • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351 (13): 1296-1305 (Pubitemid 39268908)
    • (2004) New England Journal of Medicine , vol.351 , Issue.13
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.-Y.5
  • 16
    • 0033549052 scopus 로고    scopus 로고
    • The definition of anemia in older persons
    • Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999; 281 (18): 1714-7
    • (1999) JAMA , vol.281 , Issue.18 , pp. 1714-1717
    • Izaks, G.J.1    Westendorp, R.G.2    Knook, D.L.3
  • 17
    • 44849137629 scopus 로고    scopus 로고
    • Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: The 'Health and Anemia' study
    • Lucca U, Tettamanti M, Mosconi P, et al. Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the 'Health and Anemia' study. PLoS ONE 2008; 3 (4): e1920
    • (2008) PLoS ONE , vol.3 , Issue.4
    • Lucca, U.1    Tettamanti, M.2    Mosconi, P.3
  • 20
    • 27644504938 scopus 로고    scopus 로고
    • A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: The cardiovascular health study
    • DOI 10.1001/archinte.165.19.2214
    • Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165 (19): 2214-2220 (Pubitemid 41549915)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.19 , pp. 2214-2220
    • Zakai, N.A.1    Katz, R.2    Hirsch, C.3    Shlipak, M.G.4    Chaves, P.H.M.5    Newman, A.B.6    Cushman, M.7
  • 21
    • 48149091219 scopus 로고    scopus 로고
    • Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease
    • Silver MR, Agarwal A, Krause M, et al. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease. Am J Geriatr Pharmacother 2008; 60 (2): 49-60
    • (2008) Am J Geriatr Pharmacother , vol.60 , Issue.2 , pp. 49-60
    • Silver, M.R.1    Agarwal, A.2    Krause, M.3
  • 22
    • 0037255238 scopus 로고    scopus 로고
    • Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease
    • DOI 10.1159/000068041
    • Suranyi MG, Lindberg JS, Navarro J, et al. Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease. Am J Nephrol 2003; 23 (2): 106-111 (Pubitemid 36164604)
    • (2003) American Journal of Nephrology , vol.23 , Issue.2 , pp. 106-111
    • Suranyi, M.G.1    Lindberg, J.S.2    Navarro, J.3    Elias, C.4    Brenner, R.M.5    Walker, R.6
  • 23
    • 0037384789 scopus 로고    scopus 로고
    • Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
    • DOI 10.1016/S0301-472X(03)00006-7
    • Egrie JC, Dwyer E, Browne JK, et al. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp Hematol 2003; 31 (4): 290-299 (Pubitemid 36407605)
    • (2003) Experimental Hematology , vol.31 , Issue.4 , pp. 290-299
    • Egrie, J.C.1    Dwyer, E.2    Browne, J.K.3    Hitz, A.4    Lykos, M.A.5
  • 25
    • 64249167566 scopus 로고    scopus 로고
    • Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents
    • Silver MR, Geronemus R, Krause M, et al. Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents. Curr Med Res Opin 2009; 25 (1): 123-131
    • (2009) Curr Med Res Opin , vol.25 , Issue.1 , pp. 123-131
    • Silver, M.R.1    Geronemus, R.2    Krause, M.3
  • 26
    • 4644357756 scopus 로고    scopus 로고
    • Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration
    • DOI 10.1159/000080452
    • Toto RD, Pichette V, Navarro J, et al. Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration. Am J Nephrol 2004; 24 (4): 453-460 (Pubitemid 39279389)
    • (2004) American Journal of Nephrology , vol.24 , Issue.4 , pp. 453-460
    • Toto, R.D.1    Pichette, V.2    Navarro, J.3    Brenner, R.4    Carroll, W.5    Liu, W.6    Roger, S.7
  • 27
    • 0034760560 scopus 로고    scopus 로고
    • Prediction equations to estimate glomerular filtration rate: An update
    • DOI 10.1097/00041552-200111000-00009
    • Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 2001; 10 (6): 785-792 (Pubitemid 33043673)
    • (2001) Current Opinion in Nephrology and Hypertension , vol.10 , Issue.6 , pp. 785-792
    • Manjunath, G.1    Sarnak, M.J.2    Levey, A.S.3
  • 28
    • 34548046760 scopus 로고    scopus 로고
    • KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target
    • KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50 (3): 471-530
    • (2007) Am J Kidney Dis , vol.50 , Issue.3 , pp. 471-530
  • 29
    • 33745102132 scopus 로고    scopus 로고
    • Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)
    • DOI 10.1159/000092852
    • Hertel J, Locay H, Scarlata D, et al. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from Simplify the Treatment of Anemia with Aranesp (STAAR). Am J Nephrol 2006; 26 (2): 149-156 (Pubitemid 43882399)
    • (2006) American Journal of Nephrology , vol.26 , Issue.2 , pp. 149-156
    • Hertel, J.1    Locay, H.2    Scarlata, D.3    Jackson, L.4    Prathikanti, R.5    Audhya, P.6
  • 30
    • 33748166647 scopus 로고    scopus 로고
    • Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease
    • Hertel JE, Locay HR, Scarlata DS, et al. Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease. Mayo Clin Proc 2006; 81 (9): 1188-1194
    • (2006) Mayo Clin Proc , vol.81 , Issue.9 , pp. 1188-1194
    • Hertel, J.E.1    Locay, H.R.2    Scarlata, D.S.3
  • 31
    • 33846654468 scopus 로고    scopus 로고
    • Once-Monthly Darbepoetin alfa for Maintaining Hemoglobin Levels in Older Patients with Chronic Kidney Disease
    • DOI 10.1016/j.jamda.2006.07.007, PII S1525861006003744
    • Agarwal A, Silver MR, Walczyk M, et al. Once-monthly darbepoetin alfa for maintaining hemoglobin levels in older patients with chronic kidney disease. J Am Med Dir Assoc 2007; 8 (2): 83-90 (Pubitemid 46196422)
    • (2007) Journal of the American Medical Directors Association , vol.8 , Issue.2 , pp. 83-90
    • Agarwal, A.1    Silver, M.R.2    Walczyk, M.3    Liu, W.4    Audhya, P.5
  • 32
    • 33751002326 scopus 로고    scopus 로고
    • Normalization of hemoglobin level in patients with chronic kidney disease and anemia
    • Nov 16
    • Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006 Nov 16; 355 (20): 2071-2084
    • (2006) N Engl J Med , vol.355 , Issue.20 , pp. 2071-2084
    • Drueke, T.B.1    Locatelli, F.2    Clyne, N.3
  • 34
    • 42549137081 scopus 로고    scopus 로고
    • The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis
    • Apr
    • Abu-Alfa AK, Sloan L, Charytan C, et al. The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis. Curr Med Res Opin 2008 Apr; 24 (4): 1091-1100
    • (2008) Curr Med Res Opin , vol.24 , Issue.4 , pp. 1091-1100
    • Abu-Alfa, A.K.1    Sloan, L.2    Charytan, C.3
  • 35
    • 37749012281 scopus 로고    scopus 로고
    • Association of anemia correction with health related quality of life in patients not on dialysis
    • Dec
    • Alexander M, Kewalramani R, Agodoa I, et al. Association of anemia correction with health related quality of life in patients not on dialysis. Curr Med Res Opin 2007 Dec; 23 (12): 2997-3008
    • (2007) Curr Med Res Opin , vol.23 , Issue.12 , pp. 2997-3008
    • Alexander, M.1    Kewalramani, R.2    Agodoa, I.3
  • 36
    • 3242780941 scopus 로고    scopus 로고
    • Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
    • Aug
    • Gouva C, Nikolopoulos P, Ioannidis JP, et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004 Aug; 66 (2): 753-760
    • (2004) Kidney Int , vol.66 , Issue.2 , pp. 753-760
    • Gouva, C.1    Nikolopoulos, P.2    Ioannidis, J.P.3
  • 37
    • 0035146507 scopus 로고    scopus 로고
    • Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
    • Jungers P, Choukroun G, Oualim Z, et al. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 2001 Feb; 16 (2): 307-312 (Pubitemid 32123919)
    • (2001) Nephrology Dialysis Transplantation , vol.16 , Issue.2 , pp. 307-312
    • Jungers, P.1    Choukroun, G.2    Oualim, Z.3    Robino, C.4    Nguyen, A.-T.5    Man, N.-K.6
  • 39
    • 39149111913 scopus 로고    scopus 로고
    • Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): Effects on cardiac performance
    • Feb
    • Pappas KD, Gouva CD, Katopodis KP, et al. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance. Cardiovasc Drugs Ther 2008 Feb; 22 (1): 37-44
    • (2008) Cardiovasc Drugs Ther , vol.22 , Issue.1 , pp. 37-44
    • Pappas, K.D.1    Gouva, C.D.2    Katopodis, K.P.3
  • 40
    • 0028945387 scopus 로고
    • Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
    • Apr
    • Revicki DA, Brown RE, Feeny DH, et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995 Apr; 25 (4): 548-554
    • (1995) Am J Kidney Dis , vol.25 , Issue.4 , pp. 548-554
    • Revicki, D.A.1    Brown, R.E.2    Feeny, D.H.3
  • 41
    • 33646477844 scopus 로고    scopus 로고
    • Effect of early correction of anemia on the progression of CKD
    • May
    • Rossert J, Levin A, Roger SD, et al. Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 2006 May; 47 (5): 738-750
    • (2006) Am J Kidney Dis , vol.47 , Issue.5 , pp. 738-750
    • Rossert, J.1    Levin, A.2    Roger, S.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.